Hou Ming相关文献与解析，生知库 | 链接生命科学的每一步

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial

Tucidinostat Plus R-CHOP vs R-CHOP 治疗 MYC/BCL2 双表达弥漫性大 B 细胞淋巴瘤：一项随机临床试验

期刊:Journal of the American Medical Association

doi:10.1001/jama.2026.4199

Xu, Peng-Peng; Song, Yu-Qin; Shen, Jian-Zhen; Cai, Qing-Qing; Zhou, Hui; Zhang, Li-Ling; Xiang, Ying; Sun, Xiu-Hua; Yang, Wei; Yao, Zhi-Hua; Jing, Hong-Mei; Wen, Shu-Juan; Jin, Jie; Xue, Hong-Wei; Cen, Hong; Ding, Kai-Yang; Jin, Zheng-Ming; Liu, Li-Hong; Xing, Xiao-Jing; Li, Lan-Fang; Hou, Ming; Liu, Lin; Zhang, Ming-Zhi; Li, Wen-Yu; Bai, Ou; Feng, Ru; Zhu, Zun-Min; Wu, Hui-Jing; Su, Li-Ping; Gao, Li; Li, Fei; Huang, Wen-Rong; Liu, Peng; Yan, Xiao-Jing; Zhao, Ying; Su, Hang; Zhao, Xie-Lan; Fu, Rong; Liu, Hong; Shi, Wen-Yu; Li, Hui-Zhi; Chen, Bo; Ning, Zhi-Qiang; Zhu, Jun; Zhao, Wei-Li

ATP synthasome contributes to efficient energy flux in malignant breast cancer

ATP合成酶体有助于恶性乳腺癌中高效的能量流动

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/s12943-026-02610-z

Tzeng, Yen-Dun Tony; Kang, Yu-Ting; Hsiao, Tzu-Hung; Chu, Pei-Yi; Yong, Su-Boon; Lin, Shih-Chieh; Wu, Meng-Yu; Tseng, Ling-Ming; Hou, Ming-Feng; Wen, Zhi-Hong; Hsu, Tzu-Sheng; Hung, Chih-Chiang; Chiang, An-Jen; Tsui, Kuan-Hao; Li, Chia-Jung

Adipocyte-driven STAT3-ANGPT2-PTGIS axis promotes cutaneous metastasis in breast cancer and represents a targetable pathway

脂肪细胞驱动的STAT3-ANGPT2-PTGIS轴促进乳腺癌皮肤转移，并代表一条可靶向的通路。

期刊:npj Precision Oncology

影响因子:8

doi:10.1038/s41698-025-01184-1

Luo, Chi-Wen; Ou-Yang, Fu; Chang, Shu-Jyuan; Wu, Cheng-Che; Chen, Yi-Zi; Yang, Yu-Tzu; Hsu, Mei-Chiang; Moi, Sin-Hua; Hung, Yu-Hsuan; Chu, Wan-Ling; Li, Yen-Liang; Hung, Wen-Chun; Wu, Chun-Chieh; Hou, Ming-Feng; Lin, Shu-Yi; Li, Wei-Peng; Pan, Mei-Ren

Comparison of patients with HCC with and without MASLD after surgical resection

比较手术切除后伴有和不伴有MASLD的HCC患者的差异

期刊:Jhep Reports

影响因子:7.5

doi:10.1016/j.jhepr.2026.101768

Ho, Chia-Jung; Lei, Hao-Jan; Ho, Chun-Ting; Chau, Gar-Yang; Chou, Shu-Cheng; Chia-Hui Tan, Elise; Lee, Pei-Chang; Huang, Yi-Hsiang; Yang, Ying-Ying; Huo, Teh-Ia; Hou, Ming-Chih; Wu, Jaw-Ching; Su, Chien-Wei

发表日期：2026

文献求助收藏

Genome-wide association study identifies three PNPLA3/SAMM50 SNPs associated with HCC development in non-viral liver disease

全基因组关联研究发现，PNPLA3/SAMM50基因的三个单核苷酸多态性位点与非病毒性肝病中肝细胞癌的发生发展相关。

期刊:Jhep Reports

影响因子:7.5

doi:10.1016/j.jhepr.2025.101673

Liu, Xia-Rong; Yang, Tsai-Hsuan; Su, Tung-Hung; Yin, Szu-Ching; Chen, Yi-Ting; Chen, Fen-Fang; Pang, See-Tong; Hou, Ming-Chih; Peng, Yen-Chun; Yang, Shun-Fa; Huang, Peng-Ju; Lee, Sing-Lian; Chen, Ming; Huang, Chih-Yang; Chang, Ya-Hsuan; Chen, Hsuan-Yu; Yang, Hwai-I; Yu, Ming-Lung; Chen, Chien-Jen; Kao, Jia-Horng; Lee, Mei-Hsuan

Integrating "Yang transforming Qi and Yin constituting the body" with immune regulation: an evidence synthesis of multidimensional traditional chinese medicine therapy for immune thrombocytopenia

将“阳气阴合”与免疫调节相结合：多维度中医药治疗免疫性血小板减少症的证据综合分析

期刊:Chinese Medicine

影响因子:5.7

doi:10.1186/s13020-025-01318-4

Zhou, Xin; Jiang, Yang; Hou, Ming; Shan, Ningning

AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinoma

AdvanTIG-206：一项II期随机研究，比较奥西哌利单抗联合替雷利珠单抗和BAT1706（贝伐珠单抗生物类似药）与替雷利珠单抗联合BAT1706一线治疗肝细胞癌的疗效。

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-026-04399-8

Ren, Zhenggang; Huang, Yao; Guo, Yabing; Hou, Ming-Mo; Wang, Wei; Kuang, Ming; Hao, Chunyi; Wang, Wentao; Zhang, Yanqiao; Song, Tianqiang; Dai, Chaoliu; Kuo, Hsing-Tao; Bao, Zinan; Zuo, Yunxia; Wang, Lei; Zhu, Fuxiang; Fan, Jia

Copper-Catalyzed Amino-alkoxycarbonylation of Unactivated Alkenes: Synthesis of β-Amino Esters via Primary Tosyl Amidyl Radical

铜催化未活化烯烃的氨基烷氧羰基化反应：通过伯甲苯磺酰酰胺基自由基合成β-氨基酯

期刊:Organic Letters

影响因子:5

doi:10.1021/acs.orglett.6c00774

Mao, Xudong; Hou, Ming; Wang, Yuanrui; Miao, Ren-Guan; Wu, Xiao-Feng

发表日期：2026

文献求助收藏

[Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR‑30c in breast cancer

[更正] 异林内酯通过降低乳腺癌中 miR-30c 的表达来增强 SOCS3 对 STAT3 活性的抑制作用

期刊:Oncology Reports

影响因子:3.9

doi:10.3892/or.2025.9041

Yen, Meng-Chi; Shih, Ying-Chu; Hsu, Ya-Ling; Lin, En-Shyh; Lin, Yi-Shiuan; Tsai, Eing-Mei; Ho, Ya-Wen; Hou, Ming-Feng; Kuo, Po-Lin

Recent Advances in Single-Electron-Transfer-Mediated Carbonylation

单电子转移介导羰基化反应的最新进展

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial

Tucidinostat Plus R-CHOP vs R-CHOP 治疗 MYC/BCL2 双表达弥漫性大 B 细胞淋巴瘤：一项随机临床试验

ATP synthasome contributes to efficient energy flux in malignant breast cancer

ATP合成酶体有助于恶性乳腺癌中高效的能量流动

Adipocyte-driven STAT3-ANGPT2-PTGIS axis promotes cutaneous metastasis in breast cancer and represents a targetable pathway

脂肪细胞驱动的STAT3-ANGPT2-PTGIS轴促进乳腺癌皮肤转移，并代表一条可靶向的通路。

Comparison of patients with HCC with and without MASLD after surgical resection

比较手术切除后伴有和不伴有MASLD的HCC患者的差异

Genome-wide association study identifies three PNPLA3/SAMM50 SNPs associated with HCC development in non-viral liver disease

全基因组关联研究发现，PNPLA3/SAMM50基因的三个单核苷酸多态性位点与非病毒性肝病中肝细胞癌的发生发展相关。

Integrating "Yang transforming Qi and Yin constituting the body" with immune regulation: an evidence synthesis of multidimensional traditional chinese medicine therapy for immune thrombocytopenia

将“阳气阴合”与免疫调节相结合：多维度中医药治疗免疫性血小板减少症的证据综合分析

AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinoma

AdvanTIG-206：一项II期随机研究，比较奥西哌利单抗联合替雷利珠单抗和BAT1706（贝伐珠单抗生物类似药）与替雷利珠单抗联合BAT1706一线治疗肝细胞癌的疗效。

Copper-Catalyzed Amino-alkoxycarbonylation of Unactivated Alkenes: Synthesis of β-Amino Esters via Primary Tosyl Amidyl Radical

铜催化未活化烯烃的氨基烷氧羰基化反应：通过伯甲苯磺酰酰胺基自由基合成β-氨基酯

[Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR‑30c in breast cancer

[更正] 异林内酯通过降低乳腺癌中 miR-30c 的表达来增强 SOCS3 对 STAT3 活性的抑制作用